NFKBIA and neoplasm: These results from treating the late-stage model with therapeutic IκBα-MnNPs were encouraging because, although tumor burden was not significantly affected because of the late-stage treatment, the trend of decreased ascites volume provides positive signs of a therapeutic effect.